✦ LIBER ✦

Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Scribed by Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi

Book ID: 111649774
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 214 KB
Volume: 48
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm050261p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery of Carmeg

ChemInform Abstract: Discovery of Carmegliptin (I): A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Patrizio Mattei; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views

ChemInform Abstract: Discovery of DA-122

ChemInform Abstract: Discovery of DA-1229 (I): A Potent, Long Acting Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes.

✍ Bong Jin Lee; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 20 KB 👁 1 views

RBx-0597, a potent, selective and slow-b

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes

✍ Shuchita Singh; Sachin Sethi; Vivek Khanna; Biju Benjamin; Rajiv Kant; Jitendra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 732 KB

(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-

(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a ]pyrazin- 7(8 H )-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Kim, Dooseop; Wang, Liping; Beconi, Maria; Eiermann, George J.; Fisher, Michael 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 327 KB

Erratum to “RBx-0597, a potent, selectiv

Erratum to “RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes” [European Journal of Pharmacology 652 (1–3) (2011) 157–163]

✍ Shuchita Singh; Subhasis Roy; Sachin Sethi; Biju Benjamin; Sindhuja Sundaram; Vi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Discovery of ((4 R ,5 S )-5-Amino-4-(2,4

Discovery of ((4 R ,5 S )-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8 H )-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Pei, Zhonghua; Li, Xiaofeng; von Geldern, Thomas W.; Madar, David J.; Longenecke 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 190 KB